{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:45:14Z","timestamp":1792687514325,"version":"4.5.0"},"reference-count":35,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T00:00:00Z","timestamp":1559952000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T00:00:00Z","timestamp":1559952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Thromb Thrombolysis"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1007\/s11239-019-01893-y","type":"journal-article","created":{"date-parts":[[2019,6,8]],"date-time":"2019-06-08T09:02:22Z","timestamp":1559984542000},"page":"336-344","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":11,"title":["Epidemiology and secondary prevention of ischemic stroke in patients on antiplatelet drug: a retrospective cohort study"],"prefix":"10.1007","volume":"48","author":[{"given":"Andrea","family":"Gallo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Galliazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Grazioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigina","family":"Guasti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Ageno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Squizzato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,6,8]]},"reference":[{"issue":"2018","key":"1893_CR1","first-page":"e46","volume":"49","author":"WJ Powers","year":"2018","unstructured":"Powers WJ, Rabinstein AA, Ackerson T, Adeoye OM, Bambakidis NC, Becker K, Biller J, American Heart Association Stroke Council et al (2018) Guidelines for the early management of patients with acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association. Stroke 49(2018):e46\u2013e110","journal-title":"Stroke"},{"key":"1893_CR2","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1136\/bmj.296.6618.320","volume":"296","author":"Antiplatelet Trialists\u2019 Collaboration","year":"1988","unstructured":"Antiplatelet Trialists\u2019 Collaboration (1988) Secondary prevention of vascular disease by prolonged antiplatelet treatment. Br Med J 296:320\u2013331","journal-title":"Br Med J"},{"key":"1893_CR3","doi-asserted-by":"publisher","first-page":"1849","DOI":"10.1016\/S0140-6736(09)60503-1","volume":"373","author":"J Buring","year":"2009","unstructured":"Buring J, Hennekens C, Kearney P, Meade T, Patrono C, Roncaglioni MC, Antithrombotic Trialists\u2019 (ATT) Collaboration et al (2009) Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials. Lancet 373:1849\u20131860","journal-title":"Lancet"},{"key":"1893_CR4","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1161\/CIR.0b013e318282ab8f","volume":"127","author":"AS Go","year":"2013","unstructured":"Go AS, Mozaffarian D, Roger VL, Benjamin EJ, Berry JD, Borden WB, American Heart Association Statistics Committee and Stroke Statistics Subcommittee et al (2013) Executive summary: heart disease and stroke statistics\u20132013 update\u2014a report from the American Heart Association. Circulation 127:143\u2013152","journal-title":"Circulation"},{"key":"1893_CR5","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1016\/S0140-6736(96)09457-3","volume":"348","author":"CAPRIE Steering Committee","year":"1996","unstructured":"CAPRIE Steering Committee (1996) A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). Lancet 348:1329\u20131339","journal-title":"Lancet"},{"key":"1893_CR6","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1016\/0895-4356(88)90084-4","volume":"41","author":"WHO Monica Project Principal Investigators","year":"1988","unstructured":"WHO Monica Project Principal Investigators (1988) The World Health Organization MONICA Project (monitoring trends and determinants in cardiovascular disease): a major international collaboration. J Clin Epidemiol 41:105\u2013114","journal-title":"J Clin Epidemiol"},{"key":"1893_CR7","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.1016\/0140-6736(91)93206-O","volume":"337","author":"J Bamford","year":"1991","unstructured":"Bamford J, Sandercock P, Dennis M, Burn J, Warlow C (1991) Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 337:1521\u20131526","journal-title":"Lancet"},{"key":"1893_CR8","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1161\/01.STR.24.1.35","volume":"24","author":"HP Adams Jr","year":"1993","unstructured":"Adams HP Jr, Bendixen BH, Kappelle LJ, Biller J, Love BB, Gordon Marsh DL et al (1993) Classification of subtype of acute ischemic stroke. Definition for use in a multicentre clinical trial. TOAST. Trial of Org 10172 in acute stroke treatment. Stroke 24:35\u201341","journal-title":"Stroke"},{"key":"1893_CR9","unstructured":"National Institute of Health, National Institute of Neurological Disorders and Stroke. Stroke Scale. \n                    http:\/\/www.ninds.nih.gov\/doctors\/NIH_Stroke_Scale"},{"key":"1893_CR10","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1159\/000097034","volume":"23","author":"PJ Touboul","year":"2007","unstructured":"Touboul PJ, Hennerici MG, Meairs S, Adams H, Amarenco P, Bornstein N, Csiba L et al (2007) Mannheim carotid intima-media thickness consensus (2004-2006). An update on behalf of the Advisory Board of the 3rd and 4th Watching the Risk Symposium, 13th and 15th European Stroke Conferences, Mannheim, Germany, 2004, and Brussels, Belgium, 2006. Cerebrovasc Dis 23:75\u201380","journal-title":"Cerebrovasc Dis"},{"key":"1893_CR11","doi-asserted-by":"publisher","first-page":"1710","DOI":"10.1046\/j.1538-7836.2003.00284.x","volume":"1","author":"C Patrono","year":"2003","unstructured":"Patrono C (2003) Aspirin resistance: definition, mechanisms, and clinical read-outs. J Thromb Heamost 1:1710\u20131713","journal-title":"J Thromb Heamost"},{"key":"1893_CR12","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.thromres.2018.03.011","volume":"165","author":"S Grazioli","year":"2018","unstructured":"Grazioli S, Paciaroni M, Agnelli G, Acciarresi M, Alberti A, D\u2019Amore C, Caso V, Venti M, Guasti L, Ageno W, Squizzato A (2018) Cancer-associated ischemic stroke: A retrospective multicentre cohort study. Thromb Res 165:33\u201337","journal-title":"Thromb Res"},{"key":"1893_CR13","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1016\/j.amjmed.2011.12.013","volume":"125","author":"SH Naderi","year":"2012","unstructured":"Naderi SH, Bestwick JP, Wald DS (2012) Adherence to drugs that prevent cardiovascular disease: meta-analysis on 376,162 patients. Am J Med 125:882\u2013887","journal-title":"Am J Med"},{"key":"1893_CR14","doi-asserted-by":"publisher","first-page":"2100","DOI":"10.1056\/NEJMoa1209979","volume":"367","author":"JP Collet","year":"2012","unstructured":"Collet JP, Cuisset T, Rang\u00e9 G, Cayla G, Elhadad S, Pouillot C et al (2012) ARCTIC Investigators, bedside monitoring to adjust antiplatelet therapy for coronary stenting. N Engl J Med 367:2100\u20132109","journal-title":"N Engl J Med"},{"key":"1893_CR15","doi-asserted-by":"publisher","first-page":"2610","DOI":"10.1161\/STROKEAHA.117.017895","volume":"48","author":"M Lee","year":"2017","unstructured":"Lee M, Saver JL, Hong KS, Rao NM, Wu YL, Ovbiagele B (2017) Antiplatelet regimen for patients with breakthrough strokes while on aspirin: a systematic review and meta-analysis. Stroke 48:2610\u20132613","journal-title":"Stroke"},{"key":"1893_CR16","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1056\/NEJMra050100","volume":"353","author":"L Osterberg","year":"2005","unstructured":"Osterberg L, Blaschke T (2005) Adherence to medication. N Engl J Med 353:487\u2013497","journal-title":"N Engl J Med"},{"key":"1893_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1038\/nri3345","volume":"13","author":"B Engelmann","year":"2013","unstructured":"Engelmann B, Massberg S (2013) Thrombosis as an intravascular effector of innate immunity. Nat Rev Immunol 13:34\u201345","journal-title":"Nat Rev Immunol"},{"key":"1893_CR18","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1093\/eurheartj\/ehv718","volume":"37","author":"AJ Murphy","year":"2016","unstructured":"Murphy AJ, Tall AR (2016) Disorder haemoatopoiesis and athero-thrombosis. Eur Heart J 37:1113\u20131121","journal-title":"Eur Heart J"},{"key":"1893_CR19","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1161\/CIRCRESAHA.116.309692","volume":"120","author":"Y Doring","year":"2017","unstructured":"Doring Y, Soehnlein O, Weber C (2017) Neutrophil extracellular traps in atherosclerosis and atherothrombosis. Circ Res 120:736\u2013743","journal-title":"Circ Res"},{"key":"1893_CR20","doi-asserted-by":"publisher","first-page":"223","DOI":"10.1002\/ana.24993","volume":"82","author":"E Laridan","year":"2017","unstructured":"Laridan E, Denorme F, Desender L, Francois O, Andersson T, Deckmyn H et al (2017) Neutrophil extracellular traps in ischemic stroke thrombi. Ann Neurol 82:223\u2013232","journal-title":"Ann Neurol"},{"key":"1893_CR21","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1136\/bmj.324.7329.71","volume":"324","author":"Antithrombotic Trialists\u2019 Collaboration","year":"2002","unstructured":"Antithrombotic Trialists\u2019 Collaboration (2002) Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients. BMJ 324:71\u201386","journal-title":"BMJ"},{"key":"1893_CR22","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3109\/10408363.2012.731377","volume":"49","author":"MD Linden","year":"2012","unstructured":"Linden MD, Tran HA (2012) Overcoming aspirin treatment failure in diabetes. Crit Rev Clin Lab Sci 49:183\u2013198","journal-title":"Crit Rev Clin Lab Sci"},{"key":"1893_CR23","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.prostaglandins.2012.01.008","volume":"98","author":"G Dav\u00ec","year":"2012","unstructured":"Dav\u00ec G, Vazzana N, Sestili S (2012) Variability in the response to antiplatelet treatment in diabetes mellitus. Prostaglandins Other Lipid Mediat 98:48\u201355","journal-title":"Prostaglandins Other Lipid Mediat"},{"key":"1893_CR24","doi-asserted-by":"publisher","first-page":"173124","DOI":"10.1155\/2012\/173124","volume":"2012","author":"EV Paez Espinosa","year":"2012","unstructured":"Paez Espinosa EV, Murad JP, Khasawneh FT (2012) Aspirin: pharmacology and clinical applications. Thrombosis 2012:173124","journal-title":"Thrombosis"},{"key":"1893_CR25","doi-asserted-by":"publisher","first-page":"1309","DOI":"10.1111\/j.1538-7836.2005.01351.x","volume":"3","author":"AD Michelson","year":"2005","unstructured":"Michelson AD, Cattaneo M, Eikelboom JW et al (2005) Aspirin resistance: position paper of the working group on aspirin resistance. J Thromb Haemost 3:1309\u20131311","journal-title":"J Thromb Haemost"},{"key":"1893_CR26","doi-asserted-by":"publisher","first-page":"S27","DOI":"10.1016\/j.thromres.2012.08.266","volume":"130","author":"Marco Cattaneo","year":"2012","unstructured":"Cattaneo Marco (2012) Mechanisms of variability in antiplatelet agents response. Thromb Res 130:S27\u2013S28","journal-title":"Thromb Res"},{"key":"1893_CR27","doi-asserted-by":"publisher","first-page":"382","DOI":"10.1212\/WNL.0000000000000076","volume":"82","author":"R C\u00f4t\u00e9","year":"2014","unstructured":"C\u00f4t\u00e9 R, Zhang Y, Hart RG, McClure LA, Anderson DC, Talbert RL et al (2014) ASA failure: does the combination ASA\/clopidogrel confer better long-term vascular protection? Neurology 82:382\u2013389","journal-title":"Neurology"},{"key":"1893_CR28","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","volume":"37","author":"P Kirchhof","year":"2016","unstructured":"Kirchhof P, Benussi S, Kotecha D, Ahlsson A, Atar D, Casadei B et al (2016) ESC Scientific Document Group, 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS. Eur Heart J 37:2893\u20132962","journal-title":"Eur Heart J"},{"key":"1893_CR29","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1056\/NEJMoa011258","volume":"345","author":"JP Mohr","year":"2001","unstructured":"Mohr JP, Thompson JL, Lazar RM, Levin B, Sacco RL, Furie KL et al (2001) Warfarin-aspirin recurrent stroke study group, A comparison of warfarin and aspirin for the prevention of recurrent ischemic stroke. N Engl J Med 345:1444\u20131451","journal-title":"N Engl J Med"},{"key":"1893_CR30","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/S1474-4422(13)70310-7","volume":"13","author":"RG Hart","year":"2014","unstructured":"Hart RG, Diener HC, Coutts SB, Easton JD, Granger CB, O\u2019Donnell MJ et al (2014) Embolic strokes of undetermined source: the case for a new clinical construct. Cryptogenic Stroke\/ESUS International Working Group, Lancet Neurol. 13:429\u2013438","journal-title":"Cryptogenic Stroke\/ESUS International Working Group, Lancet Neurol."},{"key":"1893_CR31","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1161\/STROKEAHA.116.016414","volume":"48","author":"RG Hart","year":"2017","unstructured":"Hart RG, Catanese L, Perera KS, Ntaios G, Connolly SJ (2017) embolic stroke of undetermined source: a systematic review and clinical update. Stroke 48:867\u2013872","journal-title":"Stroke"},{"key":"1893_CR32","doi-asserted-by":"publisher","first-page":"2191","DOI":"10.1056\/NEJMoa1802686","volume":"378","author":"RG Hart","year":"2018","unstructured":"Hart RG, Sharma M, Mundl H, Kasner SE, Bangdiwala SI, Berkowitz SD et al (2018) NAVIGATE ESUS investigators, rivaroxaban for stroke prevention after embolic stroke of undetermined source. N Engl J Med 378:2191\u20132201","journal-title":"N Engl J Med"},{"key":"1893_CR33","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1161\/STR.0b013e3181f7d043","volume":"42","author":"KL Furie","year":"2011","unstructured":"Furie KL, Kasner SE, Adams RJ, Albers GW, Bush RL, Fagan SC et al (2011) American Heart Association Stroke Council, Council on Cardiovascular Nursing, Council on Clinical Cardiology, and Interdisciplinary Council on Quality of Care and Outcomes Research, Guidelines for the prevention of stroke in patients with stroke or transient ischemic attack: a guideline for healthcare professionals from the American heart association\/American stroke association. Stroke 42:227\u2013276","journal-title":"Stroke"},{"issue":"2 Suppl","key":"1893_CR34","doi-asserted-by":"publisher","first-page":"e195S","DOI":"10.1378\/chest.11-2296","volume":"141","author":"S Kahn","year":"2012","unstructured":"Kahn S, Lim W, Dunn AS et al (2012) Prevention of VTE in non surgical patients. Chest 141(2 Suppl):e195S\u2013e226S","journal-title":"Chest"},{"key":"1893_CR35","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1212\/WNL.0000000000000092","volume":"82","author":"L Castilla-Guerra","year":"2014","unstructured":"Castilla-Guerra L, Sacco RL (2014) Treating lacunar strokes occurring on aspirin: adding clopidogrel is not the simple solution. Neurology 82:376\u2013377","journal-title":"Neurology"}],"container-title":["Journal of Thrombosis and Thrombolysis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01893-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11239-019-01893-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11239-019-01893-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,6]],"date-time":"2020-06-06T23:13:51Z","timestamp":1591485231000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11239-019-01893-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,6,8]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["1893"],"URL":"https:\/\/doi.org\/10.1007\/s11239-019-01893-y","relation":{},"ISSN":["0929-5305","1573-742X"],"issn-type":[{"value":"0929-5305","type":"print"},{"value":"1573-742X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,6,8]]},"assertion":[{"value":"8 June 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This article does not contain any studies with human participants or animals performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}}]}}